Jersey brings its wider medical cannabis prescribing rules into force

On 1 January 2019, Jersey brought a wider medical cannabis route into force. The implementing Order was made on 21 December 2018, following a political disagreement about which medical professionals should be allowed to prescribe.

The result combined broader prescribing eligibility with controls on the products that qualified. Understanding both parts helps explain the scope of the change.

A dispute about who could prescribe

Before the November 2018 vote, the health minister urged members to reject Deputy Montfort Tadier’s proposal. The minister’s published comments favoured a consultant-centred approach and pointed to professional responsibilities when prescribing unlicensed medicines.

The later ministerial decision recorded the Assembly’s contrary choice: medical professionals with existing prescribing rights should be permitted to prescribe medicinal cannabis. It explained that the Order reflected that decision despite advice favouring restriction to hospital consultants.

This was a choice about eligibility to prescribe. It did not compel an individual doctor to recommend treatment or establish that every product was suitable for every patient.

A defined class of medicines

The Order amended both the designation rules and the general drug regulations. Qualifying cannabis-related substances in medicinal products entered Schedule 2, rather than remaining within the more restrictive category from which the exception was carved out.

The definition required compliance with specified European good manufacturing practice principles and a manufacturer holding the corresponding certificate. The text therefore attached the change to a regulated product category, rather than exempting cannabis simply because someone described its intended use as medical.

Smoking remained outside the permission

A new Article 20A prohibited taking or administering the qualifying products by smoking. Broader prescribing rights consequently did not translate into permission to use the medicines by any route a patient chose.

The commencement provisions also distinguish making the Order from its operation: most provisions began on New Year’s Day, with Article 2 following immediately. December adoption and January commencement describe different stages of the same reform.

Legal access and local provision

The minister’s earlier comments distinguished permission to prescribe from publicly funded access. The reform should therefore not be read as a promise of free treatment.

A subsequent scrutiny report records the Chief Pharmacist’s account that local prescribing began in November 2020. Before that, patients used UK clinics and pharmacies. In Jersey’s timeline, the 2019 rules and the later local service belong as separate milestones: one changed the legal framework, while the other changed where residents could obtain prescriptions.^[1][2][3][4]